Clinical Pharmacology as a Foundation for Translational Science

被引：11

作者：

Waldman, S. A. ^{[1
]}

Hohl, R. J. ^{[2
,3
]}

Kearns, G. L. ^{[4
,5
]}

Swan, S. J. ^{[6
]}

Terzic, A. ^{[7
,8
,9
,10
,11
,12
]}

机构：

[1] Thomas Jefferson Univ, Dept Med, Div Clin Pharmacol, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA

[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[3] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA

[4] Childrens Mercy Hosp & Clin, Div Pediat Pharmacol, Kansas City, MO USA

[5] Childrens Mercy Hosp & Clin, Div Med Toxicol, Kansas City, MO USA

[6] Amer Soc Clin Pharmacol & Therapeut, Alexandria, VA USA

[7] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN USA

[8] Mayo Clin, Div Cardiovasc Dis, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA

[9] Mayo Clin, Div Cardiovasc Dis, Dept Med Genet, Rochester, MN USA

[10] Mayo Clin, Div Clin Pharmacol, Dept Med, Rochester, MN USA

[11] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA

[12] Mayo Clin, Div Clin Pharmacol, Dept Med Genet, Rochester, MN USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 90卷 / 01期

关键词：

THERAPEUTICS; MEDICINE;

D O I：

10.1038/clpt.2011.80

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：10 / 13

页数：4

共 50 条

[41] New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science: Joint Virtual Special Issue by Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, and ACS Pharmacology & Translational Science
Mueller, Christa E.
Hansen, Finn K.
Guetschow, Michael
Lindsley, Craig W.
Liotta, Dennis
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (19) : 13935 - 13936
[42] New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science: Joint Virtual Special Issue by Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, and ACS Pharmacology & Translational Science
Gutschow, Michael
Lindsley, Craig W.
Liotta, Dennis
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (10): : 1508 - 1509
[43] Upadacitinib: Mechanism of action, clinical, and translational science
Mohamed, Mohamed-Eslam F.
Bhatnagar, Sumit
Parmentier, Julie M.
Nakasato, Priscila
Wung, Peter
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
[44] Developing senior leadership for clinical and translational science
Libby, Anne M.
Ingbar, David H.
Nearing, Kathryn A.
Moss, Marc
Albino, Judith
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 2 (03) : 124 - 128
[45] Atogepant: Mechanism of action, clinical and translational science
Boinpally, Ramesh
Shebley, Mohamad
Trugman, Joel M.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
[46] Introduction to This Special Issue on Clinical and Translational Science
Merrick, Mark A.
Dolan, Michael G.
JOURNAL OF SPORT REHABILITATION, 2010, 19 (04) : 357 - 358
[47] Evinacumab: Mechanism of action, clinical, and translational science
Dingman, Robert
Bihorel, Sebastien
Gusarova, Viktoria
Mendell, Jeanne
Pordy, Robert
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (06):
[48] Momelotinib: Mechanism of action, clinical, and translational science
Vlasakakis, Georgios
McCabe, Michael T.
Ho, Yu Liu
Ferron-Brady, Geraldine
Martin, Paul
Bentley, Darren
Ellis, Catherine
Antonysamy, Mary
Visser, Sandra A. G.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
[49] Teclistamab: Mechanism of action, clinical, and translational science
Guo, Yue
Carde, Natalia A. Quijano
Kang, Lijuan
Verona, Raluca
Banerjee, Arnob
Kobos, Rachel
Chastain, Katherine
Uhlar, Clarissa
Pillarisetti, Kodandaram
Doyle, Margaret
Smit, Jennifer
Haddish-Berhane, Nahor
Ouellet, Daniele
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
[50] Maribavir: Mechanism of action, clinical, and translational science
Sun, Kefeng
Fournier, Martha
Sundberg, Aimee K.
Song, Ivy H.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):

← 1 2 3 4 5 →